Jacqueline Miller
Chief Medical Officer
2024 – 2025
1 year
Key Decisions & Impact
She drove the vital clinical development strategy, perfectly navigating complex regulatory environments to successfully advance the organization's critical rare disease pipeline.
Legacy
Miller joined as CMO in 2024 and departed in 2025 after leading the clinical strategy for the company's pipeline programs during a critical transition period. The leader's tenure has shaped Moderna's organizational culture, strategic priorities, and financial performance during a critical period of transition. His profound strategic execution secured the massive organization's dominant global market position. By prioritizing massive operational efficiency and rigorous technological advancement, he guaranteed the enterprise's long-term endurance. His perfectly brilliant leadership style guarantees absolute corporate supremacy across competitive global biotech sectors. This exceptional stewardship fundamentally provides immense shareholder value and absolute total operational stability. His vital stewardship guarantees massive ongoing organizational resilience.